Development of Novel Radionuclide Generators for Use in Nuclear Medicine

Introduction Over the last 5 decades, radionuclide generators have attracted substantial attention, indeed close scrutiny of the nuclear medicine community owing to their ability to provide short-lived radioisotopes without the need for on-site nuclear reactor or cyclotron facilities for preparation of a wide variety of diagnostic and therapeutic radiopharmaceuticals [1]. The radionuclide generators not only provide no-carrier-added (NCA) radionuclides on-demand basis, but also in a costeffective way where the payoff of benefits is substantial and invaluable [1]. Nuclear medicine and radionuclide generator feed off of one another, thereby, propelling both forward. Utility of radionuclide generators has virtually pervaded most areas in the field of nuclear medicine and their importance has been well demonstrated and recognized [1].